{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:01:52Z","timestamp":1776747712039,"version":"3.51.2"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.leukres.2024.107587","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:59:11Z","timestamp":1726793951000},"page":"107587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development and validation of a predictive model for tumor lysis syndrome in childhood acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"146","author":[{"given":"Yao","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianmin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoYing","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.leukres.2024.107587_bib1","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group","volume":"30","author":"Hunger","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2024.107587_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pcl.2014.09.004","article-title":"Biology of childhood acute lymphoblastic leukemia","volume":"62","author":"Bhojwani","year":"2015","journal-title":"Pediatr. Clin. North Am."},{"issue":"1","key":"10.1016\/j.leukres.2024.107587_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3324\/haematol.2015.131680","article-title":"Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome","volume":"101","author":"Oskarsson","year":"2016","journal-title":"Haematologica"},{"issue":"16","key":"10.1016\/j.leukres.2024.107587_bib4","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107587_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1053\/j.ackd.2021.09.007","article-title":"Tumor lysis syndrome","volume":"28","author":"Barbar","year":"2021","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"2","key":"10.1016\/j.leukres.2024.107587_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/17474086.2016.1127156","article-title":"Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency","volume":"9","author":"Criscuolo","year":"2016","journal-title":"Expert Rev. Hematol."},{"issue":"12","key":"10.1016\/j.leukres.2024.107587_bib7","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1634\/theoncologist.2017-0147","article-title":"In-hospital outcomes of tumor lysis syndrome: a population-based study using the national inpatient sample","volume":"22","author":"Durani","year":"2017","journal-title":"oncologist"},{"issue":"19","key":"10.1016\/j.leukres.2024.107587_bib8","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard","year":"2011","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"10.1016\/j.leukres.2024.107587_bib9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/10428190500404662","article-title":"A predictive model for the detection of tumor lysis syndrome during AML induction therapy","volume":"47","author":"Mato","year":"2006","journal-title":"Leuk. Lymphoma"},{"issue":"8","key":"10.1016\/j.leukres.2024.107587_bib10","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/cncr.22990","article-title":"Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome","volume":"110","author":"Truong","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2024.107587_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3324\/haematol.11575","article-title":"Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model","volume":"93","author":"Montesinos","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2024.107587_bib12","doi-asserted-by":"crossref","unstructured":"G.S. Collins, J.B. Reitsma, D.G. Altman, K.G. Moons, Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement, {C}B.M.J. (Clinical{C} research ed.) 350 (2015) g7594.","DOI":"10.1136\/bmj.g7594"},{"issue":"9","key":"10.1016\/j.leukres.2024.107587_bib13","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.6004\/jnccn.2021.0042","article-title":"Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Brown","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw.: JNCCN"},{"issue":"12","key":"10.1016\/j.leukres.2024.107587_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(13)70452-2","article-title":"Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian oncology summit 2013","volume":"14","author":"Yeoh","year":"2013","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107587_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood.2020010438","article-title":"Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation","volume":"138","author":"Tang","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2024.107587_bib16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF00860751","article-title":"Tumor lysis syndrome: pathogenesis and management","volume":"9","author":"Jones","year":"1995","journal-title":"Pediatr. Nephrol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107587_bib17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2141.2010.08143.x","article-title":"Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus","volume":"149","author":"Cairo","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.leukres.2024.107587_bib18","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1056\/NEJMcp1001011","article-title":"Clinical practice. Calcium kidney stones","volume":"363","author":"Worcester","year":"2010","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"10.1016\/j.leukres.2024.107587_bib19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bjh.13403","article-title":"Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British committee for standards in haematology","volume":"169","author":"Jones","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2024.107587_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107587_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107587_bib22","first-page":"3591","article-title":"Nomogram for predicting the survival of patients with malignant melanoma: a population analysis","volume":"18","author":"Yang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.leukres.2024.107587_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12957-021-02445-6","article-title":"A nomogram model for predicting prognosis of obstructive colorectal cancer","volume":"19","author":"Lv","year":"2021","journal-title":"World J. Surg. Oncol."},{"issue":"9","key":"10.1016\/j.leukres.2024.107587_bib24","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1245\/s10434-022-11911-8","article-title":"Survival nomogram for young breast cancer patients based on the SEER database and an external validation cohort","volume":"29","author":"Huang","year":"2022","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2024.107587_bib25","doi-asserted-by":"crossref","first-page":"9656","DOI":"10.1038\/s41598-021-88912-2","article-title":"Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia","volume":"11","author":"Xue","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.leukres.2024.107587_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S0272-6386(99)70062-4","article-title":"Hyperuricemia and renal insufficiency associated with malignant disease: urate oxidase as an efficient therapy?","volume":"34","author":"Wolf","year":"1999","journal-title":"Am. J. Kidney Dis.: Off. J. Natl. Kidney Found."},{"issue":"2","key":"10.1016\/j.leukres.2024.107587_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0002-9343(93)90174-N","article-title":"Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma","volume":"94","author":"Hande","year":"1993","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.leukres.2024.107587_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ackd.2013.07.001","article-title":"Tumor lysis syndrome: new challenges and recent advances","volume":"21","author":"Wilson","year":"2014","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.leukres.2024.107587_bib29","doi-asserted-by":"crossref","first-page":"9684909","DOI":"10.1155\/2017\/9684909","article-title":"Tumor lysis syndrome in patients with hematological malignancies","volume":"2017","author":"Belay","year":"2017","journal-title":"J. Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107587_bib30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00277-015-2585-7","article-title":"Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review","volume":"95","author":"Howard","year":"2016","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107587_bib31","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/bjh.16278","article-title":"Emergencies in haematology: tumour lysis syndrome","volume":"188","author":"Durani","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2024.107587_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5152\/tjh.2011.06","article-title":"Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin's lymphoma and acute lymphoblastic leukemia","volume":"28","author":"Sevinir","year":"2011","journal-title":"Turk. J. Haematol.: Off. J. Turk. Soc. Haematol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107587_bib33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bjh.12415","article-title":"Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the groupe de recherche en r\u00e9animation respiratoire et onco-h\u00e9matologique","volume":"162","author":"Darmon","year":"2013","journal-title":"Br. J. Haematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521262400153X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521262400153X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T17:48:28Z","timestamp":1729878508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014521262400153X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":33,"alternative-id":["S014521262400153X"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107587","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a predictive model for tumor lysis syndrome in childhood acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107587"}}